CRP and prostate carcinoma: Accordingly, a systemic inflammatory response as shown by an elevated concentration of circulating C-reactive protein (CRP) in peripheral blood, has frequently been associated with increased incidence as well as worse outcome in numerous types of cancer, e.g. gastro-oesophageal cancer, non-small cell lung cancer and prostate cancer [8]–[11].